Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in CVS Health Corporation $CVS

Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the third quarter, HoldingsChannel reports. The firm bought 8,428 shares of the pharmacy operator’s stock, valued at approximately $635,000.

Several other large investors have also recently added to or reduced their stakes in CVS. Harbor Capital Advisors Inc. raised its holdings in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC bought a new position in shares of CVS Health during the third quarter valued at approximately $29,000. Front Row Advisors LLC boosted its position in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in CVS Health in the second quarter worth $36,000. Finally, SOA Wealth Advisors LLC. boosted its holdings in shares of CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 131 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

Shares of CVS opened at $77.00 on Tuesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The company has a market capitalization of $97.96 billion, a price-to-earnings ratio of 55.80, a P/E/G ratio of 0.80 and a beta of 0.50. The business’s 50-day moving average is $78.47 and its 200-day moving average is $76.96. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. During the same quarter in the prior year, the business earned $1.19 EPS. The company’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s dividend payout ratio is 192.75%.

Analyst Upgrades and Downgrades

Several brokerages have commented on CVS. Sanford C. Bernstein restated a “market perform” rating and issued a $91.00 price target on shares of CVS Health in a research note on Tuesday, January 6th. UBS Group reiterated an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. Wells Fargo & Company decreased their target price on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. Mizuho lifted their price objective on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Finally, Raymond James Financial raised their price objective on CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.